CATB

Catabasis Pharmaceuticals, Inc. Common Stock

$1.72 +$0.04 +2.62%



Shares Bought4
Shares Sold4
Total8
Shares Owned0
Last Price$1.72
Total Return$0.81
Range Today$1.62 - $1.81
52 Week Range$1.09 - $3.78
Open$1.66
Market Cap$38.35M
Volume/Average1.05M/1.04M
P/E Ratio-
Dividend/Yield-




Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of therapeutics for the treatment of cardiovascular, metabolic and inflammatory diseases. The company was founded by Jill C. Milne, Michael Jirousek and Steven Shoelson on June 26, 2008 and is headquartered in Cambridge, MA.


Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-10-05 16:40 17-10-05 17:49 $2.86 $2.61 -$0.25 -8.74% shrx1
17-10-03 16:49 17-10-04 17:35 $2.64 $3.26 +$0.62 +23.53% crizisaround genovahero
17-10-09 20:57 17-10-11 15:16 $2.50 $2.30 -$0.20 -7.96% genovahero
17-10-02 15:37 17-10-04 17:33 $2.62 $3.26 +$0.64 +24.47% funkmasterflexion